Article
Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis
21 Apr 2022
Abstract excerpt
Background: Despite the availability of various therapy options and being a widely focused research area, the prognosis of glioblastoma (GBM) still remains very poor due to therapy resistance, genetic heterogeneity and a diffuse infiltration pattern. The recently described non-apoptotic form of cell death ferroptosis may, however, offer novel opportunities for targeted therapies. Hence, the aim of this study was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
